Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.90 in the prior trading day, OptiNose Inc (NASDAQ: OPTN) closed at $0.86, down -4.93%. In other words, the price has decreased by -$4.93 from its previous closing price. On the day, 3.14 million shares were traded. OPTN stock price reached its highest trading level at $0.9136 during the session, while it also had its lowest trading level at $0.8.
Ratios:
Our goal is to gain a better understanding of OPTN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 0.60.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 11, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On August 21, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’24 when Mahmoud Ramy A sold 19,198 shares for $1.88 per share. The transaction valued at 36,092 led to the insider holds 1,331,278 shares of the business.
Marino Michael F III sold 15,059 shares of OPTN for $28,311 on Mar 18 ’24. The Chief Legal Officer & Corp Sec now owns 602,268 shares after completing the transaction at $1.88 per share. On Mar 18 ’24, another insider, Krick Anthony J, who serves as the Chief Accounting Officer of the company, sold 2,345 shares for $1.88 each. As a result, the insider received 4,409 and left with 143,988 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPTN now has a Market Capitalization of 96925784 and an Enterprise Value of 154990560. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37. Its current Enterprise Value per Revenue stands at 2.183 whereas that against EBITDA is -6.936.
Stock Price History:
The Beta on a monthly basis for OPTN is -0.13, which has changed by -0.5168539 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, OPTN has reached a high of $2.10, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -41.41%, while the 200-Day Moving Average is calculated to be -33.26%.
Shares Statistics:
The stock has traded on average 988.71K shares per day over the past 3-months and 3157550 shares per day over the last 10 days, according to various share statistics. A total of 112.40M shares are outstanding, with a floating share count of 80.41M. Insiders hold about 28.62% of the company’s shares, while institutions hold 56.76% stake in the company. Shares short for OPTN as of 1713139200 were 3212525 with a Short Ratio of 3.25, compared to 1710460800 on 3201562. Therefore, it implies a Short% of Shares Outstanding of 3212525 and a Short% of Float of 3.2899998.
Earnings Estimates
The market rating for OptiNose Inc (OPTN) is a result of the insights provided by 4.0 analysts actively involved in the assessment.On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.12, while EPS last year was -$0.17. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.24 and -$0.28 for the fiscal current year, implying an average EPS of -$0.26. EPS for the following year is -$0.1, with 4.0 analysts recommending between -$0.04 and -$0.18.
Revenue Estimates
4 analysts predict $12.94M in revenue for the current quarter. It ranges from a high estimate of $13.1M to a low estimate of $12.66M. As of the current estimate, OptiNose Inc’s year-ago sales were $11.85MFor the next quarter, 4 analysts are estimating revenue of $21.23M. There is a high estimate of $21.9M for the next quarter, whereas the lowest estimate is $20.51M.
A total of 4 analysts have provided revenue estimates for OPTN’s current fiscal year. The highest revenue estimate was $94.73M, while the lowest revenue estimate was $84.87M, resulting in an average revenue estimate of $91.38M. In the same quarter a year ago, actual revenue was $70.99MBased on 4 analysts’ estimates, the company’s revenue will be $129.92M in the next fiscal year. The high estimate is $143.1M and the low estimate is $103.18M.
